GMPharma Consult ApS — Credit Rating and Financial Key Figures

GMPharma Consult ApS (CVR number: 42760137) is a company from HILLERØD. The company recorded a gross profit of -14.2 kDKK in 2023, demonstrating a decline of 0 % compared to the previous year. The operating profit was -14.5 kDKK, while net earnings were -12.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -8.5 %, which can be considered poor and Return on Equity (ROE) was -9.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 76.7 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. GMPharma Consult ApS's liquidity measured by quick ratio was 4.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.